HEADER IMMUNE SYSTEM 29-NOV-20 7KVX TITLE STRUCTURE OF HSTING IN COMPLEX WITH NOVEL CARBOCYCLIC PYRIMIDINE CDN 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TRANSMEMBRANE PROTEIN 173; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STING, LOC340061, HCG_1782396; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS IMMUNOTHERAPY, STIMULATOR OF INTERFERON GENES, CYCLIC DINUCLEOTIDE, KEYWDS 2 IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.SKENE REVDAT 3 18-OCT-23 7KVX 1 REMARK REVDAT 2 09-JUN-21 7KVX 1 JRNL REVDAT 1 02-JUN-21 7KVX 0 JRNL AUTH S.VYSKOCIL,D.CARDIN,J.CIAVARRI,J.CONLON,C.CULLIS,D.ENGLAND, JRNL AUTH 2 R.GERSHMAN,K.GIGSTAD,K.GIPSON,A.GOULD,P.GREENSPAN,R.GRIFFIN, JRNL AUTH 3 N.GULAVITA,S.HARRISON,Z.HU,Y.HU,A.HATA,J.HUANG,S.C.HUANG, JRNL AUTH 4 D.JANOWICK,M.JONES,V.KOLEV,S.P.LANGSTON,H.M.LEE,G.LI,D.LOK, JRNL AUTH 5 L.MA,D.MAI,J.MALLEY,A.MATSUDA,H.MIZUTANI,M.MIZUTANI, JRNL AUTH 6 N.MOLCHANOVA,E.NUNES,S.PUSALKAR,C.RENOU,S.ROWLAND,Y.SATO, JRNL AUTH 7 M.SHAW,L.SHEN,Z.SHI,R.SKENE,F.SOUCY,S.STROUD,H.XU,T.XU, JRNL AUTH 8 A.O.ABU-YOUSIF,J.ZHANG JRNL TITL IDENTIFICATION OF NOVEL CARBOCYCLIC PYRIMIDINE CYCLIC JRNL TITL 2 DINUCLEOTIDE STING AGONISTS FOR ANTITUMOR IMMUNOTHERAPY JRNL TITL 3 USING SYSTEMIC INTRAVENOUS ROUTE. JRNL REF J.MED.CHEM. V. 64 6902 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34000802 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00374 REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0257 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 8377 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 420 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.48 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 601 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.37 REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE SET COUNT : 26 REMARK 3 BIN FREE R VALUE : 0.4370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1465 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 46 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.13000 REMARK 3 B22 (A**2) : 0.23000 REMARK 3 B33 (A**2) : -0.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.24000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.388 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.263 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.245 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.755 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1541 ; 0.006 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 1361 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2095 ; 1.574 ; 1.690 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3151 ; 1.237 ; 1.568 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 179 ; 6.987 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 96 ;28.962 ;21.562 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 255 ;16.257 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;20.050 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 197 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1749 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 332 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 152 A 401 REMARK 3 ORIGIN FOR THE GROUP (A): 29.7099 7.8942 17.3516 REMARK 3 T TENSOR REMARK 3 T11: 0.0251 T22: 0.0709 REMARK 3 T33: 0.0503 T12: -0.0003 REMARK 3 T13: -0.0310 T23: -0.0022 REMARK 3 L TENSOR REMARK 3 L11: 0.8294 L22: 1.2521 REMARK 3 L33: 0.5076 L12: -0.5541 REMARK 3 L13: 0.1450 L23: 0.2568 REMARK 3 S TENSOR REMARK 3 S11: -0.0290 S12: -0.0507 S13: 0.0751 REMARK 3 S21: -0.0742 S22: -0.0075 S23: 0.1295 REMARK 3 S31: 0.0242 S32: -0.0981 S33: 0.0364 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 7KVX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1000253256. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-AUG-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1806 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8802 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 44.460 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 1.26900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4KSY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26.0% PEG 3350, 0.200M AMMONIUM REMARK 280 SULFATE, 0.1M BIS-TRIS PH 7.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.74750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.26950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.74750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.26950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 85.40606 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 35.77710 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 527 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 137 REMARK 465 GLY A 138 REMARK 465 SER A 139 REMARK 465 ALA A 140 REMARK 465 PRO A 141 REMARK 465 ALA A 142 REMARK 465 GLU A 143 REMARK 465 ILE A 144 REMARK 465 SER A 145 REMARK 465 ALA A 146 REMARK 465 VAL A 147 REMARK 465 CYS A 148 REMARK 465 GLU A 149 REMARK 465 LYS A 150 REMARK 465 GLY A 151 REMARK 465 ALA A 318 REMARK 465 ASP A 319 REMARK 465 ASP A 320 REMARK 465 SER A 321 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 GLU A 339 REMARK 465 GLU A 340 REMARK 465 VAL A 341 REMARK 465 THR A 342 REMARK 465 VAL A 343 REMARK 465 GLY A 344 REMARK 465 SER A 345 REMARK 465 LEU A 346 REMARK 465 LYS A 347 REMARK 465 THR A 348 REMARK 465 SER A 349 REMARK 465 ALA A 350 REMARK 465 VAL A 351 REMARK 465 PRO A 352 REMARK 465 SER A 353 REMARK 465 THR A 354 REMARK 465 SER A 355 REMARK 465 THR A 356 REMARK 465 MET A 357 REMARK 465 SER A 358 REMARK 465 GLN A 359 REMARK 465 GLU A 360 REMARK 465 PRO A 361 REMARK 465 GLU A 362 REMARK 465 LEU A 363 REMARK 465 LEU A 364 REMARK 465 ILE A 365 REMARK 465 SER A 366 REMARK 465 GLY A 367 REMARK 465 MET A 368 REMARK 465 GLU A 369 REMARK 465 LYS A 370 REMARK 465 PRO A 371 REMARK 465 LEU A 372 REMARK 465 PRO A 373 REMARK 465 LEU A 374 REMARK 465 ARG A 375 REMARK 465 THR A 376 REMARK 465 ASP A 377 REMARK 465 PHE A 378 REMARK 465 SER A 379 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 305 O HOH A 501 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 167 -67.96 -148.24 REMARK 500 ARG A 197 138.85 75.11 REMARK 500 GLN A 306 47.92 -107.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue X5J A 401 DBREF1 7KVX A 140 379 UNP A0A2R3XZB7_HUMAN DBREF2 7KVX A A0A2R3XZB7 140 379 SEQADV 7KVX GLY A 137 UNP A0A2R3XZB EXPRESSION TAG SEQADV 7KVX GLY A 138 UNP A0A2R3XZB EXPRESSION TAG SEQADV 7KVX SER A 139 UNP A0A2R3XZB EXPRESSION TAG SEQRES 1 A 243 GLY GLY SER ALA PRO ALA GLU ILE SER ALA VAL CYS GLU SEQRES 2 A 243 LYS GLY ASN PHE ASN VAL ALA HIS GLY LEU ALA TRP SER SEQRES 3 A 243 TYR TYR ILE GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU SEQRES 4 A 243 GLN ALA ARG ILE ARG THR TYR ASN GLN HIS TYR ASN ASN SEQRES 5 A 243 LEU LEU ARG GLY ALA VAL SER GLN ARG LEU TYR ILE LEU SEQRES 6 A 243 LEU PRO LEU ASP CYS GLY VAL PRO ASP ASN LEU SER MET SEQRES 7 A 243 ALA ASP PRO ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN SEQRES 8 A 243 GLN THR GLY ASP ARG ALA GLY ILE LYS ASP ARG VAL TYR SEQRES 9 A 243 SER ASN SER ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG SEQRES 10 A 243 ALA GLY THR CYS VAL LEU GLU TYR ALA THR PRO LEU GLN SEQRES 11 A 243 THR LEU PHE ALA MET SER GLN TYR SER GLN ALA GLY PHE SEQRES 12 A 243 SER ARG GLU ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS SEQRES 13 A 243 ARG THR LEU GLU ASP ILE LEU ALA ASP ALA PRO GLU SER SEQRES 14 A 243 GLN ASN ASN CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA SEQRES 15 A 243 ASP ASP SER SER PHE SER LEU SER GLN GLU VAL LEU ARG SEQRES 16 A 243 HIS LEU ARG GLN GLU GLU LYS GLU GLU VAL THR VAL GLY SEQRES 17 A 243 SER LEU LYS THR SER ALA VAL PRO SER THR SER THR MET SEQRES 18 A 243 SER GLN GLU PRO GLU LEU LEU ILE SER GLY MET GLU LYS SEQRES 19 A 243 PRO LEU PRO LEU ARG THR ASP PHE SER HET X5J A 401 41 HETNAM X5J (2R,5R,7R,8R,10R,12AR,14R,15AS,16R)-7-(2-AMINO-6-OXO-1, HETNAM 2 X5J 6-DIHYDRO-9H-PURIN-9-YL)-16-HYDROXY-14-[(PYRIMIDIN-4- HETNAM 3 X5J YL)AMINO]-2,10-DISULFANYLDECAHYDRO-2H,10H-5,8-METHANO- HETNAM 4 X5J 2LAMBDA~5~,10LAMBDA~5~-CYCLOPENTA[L][1,3,6,9,11,2, HETNAM 5 X5J 10]PENTAOXADIPHOSPHACYCLOTETRADECINE-2,10-DIONE FORMUL 2 X5J C20 H26 N8 O9 P2 S2 FORMUL 3 HOH *46(H2 O) HELIX 1 AA1 PHE A 153 TYR A 167 1 15 HELIX 2 AA2 TYR A 167 LEU A 172 1 6 HELIX 3 AA3 GLU A 174 TYR A 186 1 13 HELIX 4 AA4 ASN A 211 ALA A 215 5 5 HELIX 5 AA5 ALA A 262 TYR A 274 1 13 HELIX 6 AA6 SER A 275 GLY A 278 5 4 HELIX 7 AA7 SER A 280 ASP A 301 1 22 HELIX 8 AA8 SER A 324 ARG A 334 1 11 SHEET 1 AA1 5 ILE A 219 LYS A 224 0 SHEET 2 AA1 5 SER A 243 GLU A 249 -1 O ILE A 244 N ASP A 223 SHEET 3 AA1 5 GLN A 252 TYR A 261 -1 O GLN A 252 N GLU A 249 SHEET 4 AA1 5 LEU A 198 PRO A 203 1 N LEU A 201 O GLU A 260 SHEET 5 AA1 5 CYS A 309 TYR A 314 1 O ARG A 310 N LEU A 198 SHEET 1 AA2 2 GLN A 228 ARG A 232 0 SHEET 2 AA2 2 ILE A 235 TYR A 240 -1 O TYR A 240 N GLN A 228 SITE 1 AC1 13 SER A 162 TYR A 163 TYR A 167 ARG A 238 SITE 2 AC1 13 TYR A 240 THR A 263 PRO A 264 THR A 267 SITE 3 AC1 13 HOH A 504 HOH A 509 HOH A 511 HOH A 514 SITE 4 AC1 13 HOH A 531 CRYST1 89.495 78.539 36.010 90.00 96.52 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011174 0.000000 0.001276 0.00000 SCALE2 0.000000 0.012733 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027951 0.00000